These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11225590)

  • 1. Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16.
    Smahel M; Sobotková E; Bubeník J; Símová J; Zák R; Ludviková V; Hájková R; Kovarík J; Jelínek F; Povýsil C; Marinov J; Vonka V
    Br J Cancer; 2001 Feb; 84(3):374-80. PubMed ID: 11225590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA vaccine against oncogenic hamster cells transformed by HPV16 E6/E7 oncogenes and the activated ras oncogene.
    Smahel M; Sobotkova E; Vonka V; Hamsikova E; Zak R; Kitasato H; Ludvikova V
    Oncol Rep; 1999; 6(1):211-5. PubMed ID: 9864430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
    Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
    Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class I+ and class I- HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments.
    Símová J; Mikysková R; Vonka V; Bieblová J; Bubeník J; Jandlová T
    Folia Biol (Praha); 2003; 49(6):230-4. PubMed ID: 14748438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules.
    Smahel M; Síma P; Ludvíková V; Marinov I; Pokorná D; Vonka V
    Vaccine; 2003 Mar; 21(11-12):1125-36. PubMed ID: 12559790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
    Indrová M; Bubeník J; Mikysková R; Vonka V; Smahel M; Zák R; Símová J; Bieblová J; Mendoza L; Jandlová T
    Int J Oncol; 2002 Mar; 20(3):643-6. PubMed ID: 11836582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local IFN-gamma therapy of HPV16-associated tumours.
    Mikysková R; Bieblová J; Símová J; Indrová M; Jandlová T; Vonka V; Smahel M; Bubeník J; Mendoza L
    Folia Biol (Praha); 2003; 49(1):26-32. PubMed ID: 12630665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live cell vaccines expressing B7.1, monocyte chemoattractant protein 1 and granulocyte-macrophage colony stimulation factor derived from mouse HPV16-transformed cells.
    Lakatosová-Andelová M; Jinoch P; Dusková M; Marinov I; Vonka V
    Int J Oncol; 2008 Jan; 32(1):265-71. PubMed ID: 18097567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined immunization with fusion genes of mutated E7 gene of human papillomavirus type 16 did not enhance antitumor effect.
    Pokorná D; Macková J; Dusková M; Rittich S; Ludvíková V; Smahel M
    J Gene Med; 2005 Jun; 7(6):696-707. PubMed ID: 15712328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A DNA vaccine constructed with human papillomavirus type 16 (HPV16) E7 and E6 genes induced specific immune responses.
    Yan Q; Cheung YK; Cheng SC; Wang XH; Shi M; Hu MH; Yong X
    Gynecol Oncol; 2007 Jan; 104(1):199-206. PubMed ID: 17049969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cell lines derived from tumors induced by TC-1 cells in mice preimmunized against HPV16 E7 oncoprotein.
    Smahel M; Smahelová J; Tejklová P; Tachezy R; Marinov I
    Int J Oncol; 2005 Sep; 27(3):731-42. PubMed ID: 16077923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
    Bubeník J; Símová J; Hájková R; Sobota V; Jandlová T; Smahel M; Sobotková E; Vonka V
    Int J Oncol; 1999 Mar; 14(3):593-7. PubMed ID: 10024696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours.
    Mendoza L; Bubeník J; Símová J; Jandlová T; Vonka V; Mikysková R
    Int J Oncol; 2003 Jul; 23(1):243-7. PubMed ID: 12792800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
    Sobotková E; Dusková M; Smahel M; Holán V; Janousková O; Vonka V
    Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.
    Mikysková R; Bubenik J; Mendoza L; Vonka V; Smahel M; Símová J; Jandlová T
    Clin Exp Metastasis; 2000; 18(7):581-7. PubMed ID: 11688963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccine encoding endosome-targeted human papillomavirus type 16 E7 protein generates CD4+ T cell-dependent protection.
    Brulet JM; Maudoux F; Thomas S; Thielemans K; Burny A; Leo O; Bex F; Hallez S
    Eur J Immunol; 2007 Feb; 37(2):376-84. PubMed ID: 17274002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelium and fibroblast-like phenotypes derived from HPV16 E6/E7-immortalized human gingival keratinocytes following chronic ethanol treatment.
    Chamulitrat W; Schmidt R; Chunglok W; Kohl A; Tomakidi P
    Eur J Cell Biol; 2003 Jun; 82(6):313-22. PubMed ID: 12868599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.